Literature DB >> 17786951

In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them.

Domizio Suva1, Jakob Passweg, Serge Arnaudeau, Pierre Hoffmeyer, Vincent Kindler.   

Abstract

The regulatory effect of human multipotent mesenchymal stromal cells (MSC) on allogenic T lymphocytes is extremely powerful and of important clinical relevance, but the mechanisms underlying this process are not fully elucidated. We report here that T lymphocytes activated with a sub-mitogenic stimulus such as phytohemaglutinin alone (PHA), or with mitogenic stimuli such as PHA + interleukin-2 (P-IL2), or immobilized anti-CD3 + anti-CD28 mAb (a3-28), tightly bound allogenic MSC and transmigrated within 4 h under them, where they remained for approximately 60 h. Allogenic MSC induced T cell proliferation in cultures containing sub-mitogenic PHA concentrations, and inhibited the mitogenic effect of P-IL2 or a3-28. Anti-gamma-IFN mAb or L-tryptophan complementation partially restored proliferation in P-IL2 and a3-28 cultures, whereby gamma-IFN-synthesizing CD3+ cells were detectable. MSC-lymphocyte contact hindrance using transwells abrogated proliferation in PHA cultures, restored it integrally in P-IL2 cultures, and partially in a3-28 cultures. These data suggest that MSC-induced T lymphocyte regulation results from the combination of various processes. Allogenic cell-cell contact, as demonstrated by the PHA co-cultures is per se stimulatory, whereas gamma-IFN synthesized by activated T lymphocytes, which activates indolamine 2,3-dioxygenase in MSC, and L-tryptophan depletion, which is induced by this enzyme, are inhibitory. Transmigration is nevertheless pivotal for the establishment of the inhibition by these mediators because it targets lymphocytes under the stroma in small extracellular spaces surrounded by MSC, where L-tryptophan is efficiently destroyed, leading to T lymphocyte proliferation arrest. In conclusion lymphocyte transmigration under allogenic MSC potentiates the inhibitory effect of soluble mediators generated by these cells. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17786951     DOI: 10.1002/jcp.21244

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  16 in total

Review 1.  Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro.

Authors:  Aleksandra Gornostaeva; Elena Andreeva; Ludmila Buravkova
Journal:  Cytotechnology       Date:  2015-08-13       Impact factor: 2.058

2.  Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis.

Authors:  Mehdi Najar; Gordana Raicevic; Hussein Fayyad-Kazan; Cécile De Bruyn; Dominique Bron; Michel Toungouz; Laurence Lagneaux
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

3.  EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells.

Authors:  Nicolò Riggi; Mario-Luca Suvà; Claudio De Vito; Paolo Provero; Jean-Christophe Stehle; Karine Baumer; Luisa Cironi; Michalina Janiszewska; Tanja Petricevic; Domizio Suvà; Stéphane Tercier; Jean-Marc Joseph; Louis Guillou; Ivan Stamenkovic
Journal:  Genes Dev       Date:  2010-04-09       Impact factor: 11.361

4.  Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells.

Authors:  Sandrine Cappellesso-Fleury; Bénédicte Puissant-Lubrano; Pol-André Apoil; Matthias Titeux; Peter Winterton; Louis Casteilla; Philippe Bourin; Antoine Blancher
Journal:  J Clin Immunol       Date:  2010-04-20       Impact factor: 8.317

5.  Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?

Authors:  Timothy E Krueger; Daniel L J Thorek; Alan K Meeker; John T Isaacs; W Nathaniel Brennen
Journal:  Prostate       Date:  2018-11-28       Impact factor: 4.104

6.  Interaction of allogeneic adipose tissue-derived stromal cells and unstimulated immune cells in vitro: the impact of cell-to-cell contact and hypoxia in the local milieu.

Authors:  Aleksandra N Gornostaeva; Elena R Andreeva; Polina I Bobyleva; Ludmila B Buravkova
Journal:  Cytotechnology       Date:  2017-10-03       Impact factor: 2.058

7.  Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.

Authors:  Rachele Ciccocioppo; Giuseppina C Cangemi; Peter Kruzliak; Alessandra Gallia; Elena Betti; Carla Badulli; Miryam Martinetti; Marila Cervio; Alessandro Pecci; Valeria Bozzi; Paolo Dionigi; Livia Visai; Antonella Gurrado; Costanza Alvisi; Cristina Picone; Manuela Monti; Maria E Bernardo; Paolo Gobbi; Gino R Corazza
Journal:  Stem Cell Res Ther       Date:  2015-07-24       Impact factor: 6.832

Review 8.  Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far?

Authors:  Rodrigo Haddad; Felipe Saldanha-Araujo
Journal:  Biomed Res Int       Date:  2014-06-16       Impact factor: 3.411

9.  Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1.

Authors:  Luisa Cironi; Paolo Provero; Nicola Riggi; Michalina Janiszewska; Domizio Suva; Mario-Luca Suva; Vincent Kindler; Ivan Stamenkovic
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

10.  IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.

Authors:  Luisa Cironi; Nicolò Riggi; Paolo Provero; Natalie Wolf; Mario-Luca Suvà; Domizio Suvà; Vincent Kindler; Ivan Stamenkovic
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.